According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Marks remarkable acceleration in innovation using AI technology
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
NEIAFMR to be developed as the national hub for folk medicine
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Subscribe To Our Newsletter & Stay Updated
